Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Jevtana launched in U.S. for metastatic hormone-refractory prostate cancer

July 20, 2010

Health Canada clears phase III ReoT3D trial in head and neck cancer

July 20, 2010

FDA approves Lorus Therapeutics' IND for anticancer agent LOR-253

July 20, 2010

Amgen's denosumab BLA receives FDA priority review status

July 19, 2010

Chinese scientists identify novel protein kinase inhibitors

July 19, 2010

Merck KGaA identifies new tyrosine kinase inhibitors

July 16, 2010

FDA grants orphan drug status to Keryx's perifosine for neuroblastoma

July 16, 2010

Vertex scientists present new ATR kinase inhibitors

July 16, 2010

ChemGenex to submit new NDA for Omapro as third-line CML therapy

July 15, 2010

Peregrine begins second phase IIb trial of bavituximab in NSCLC

July 15, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...